Literature DB >> 20448519

Successful treatment of bipolar disorder II and ADHD with a micronutrient formula: a case study.

Julia J Rucklidge1, Rachel Harrison.   

Abstract

Bipolar disorder with co-occurring attention-deficit/hyperactivity disorder (ADHD) is a challenge to treat. Ten previous reports have shown potential benefit of a micronutrient treatment (consisting mainly of vitamins and minerals) for various psychiatric symptoms, including mood and ADHD. This case study aimed to investigate the longer term impact of the micronutrients on both psychiatric and neurocognitive functioning in an off-on-off-on (ABAB) design with 1 year follow-up. A 21-year-old female with bipolar II disorder, ADHD, social anxiety, and panic disorder entered an open-label trial using a nutritional treatment following a documented 8 year history of on-going psychiatric symptoms not well managed by medications. After 8 weeks on the formula she showed significant improvements in mood, anxiety, and hyperactivity/impulsivity. Blood test results remained normal after 8 weeks on the formula. She did not report any adverse side effects associated with the treatment. She then chose to come off the formula; after 8 weeks her depression scores returned to baseline, and anxiety and ADHD symptoms worsened. The formula was reintroduced, showing gradual improvement in all psychiatric symptoms. This case represents a naturalistic ABAB design showing on-off control of symptoms. After 1 year, the patient is now in remission from all mental illness. Neurocognitive changes mirrored behavioral changes, showing improved processing speed, consistency in response speed, and verbal memory. A placebo response and expectancy effects cannot be ruled out although previous poor response to treatment and the duration of the current positive response decrease the likelihood that other factors better explain change. These consistently positive outcomes alongside an absence of side effects indicate that further research, particularly larger and more controlled trials, is warranted using this multinutrient approach.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20448519     DOI: 10.1017/s1092852900027516

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  9 in total

1.  Efficacy and cost of micronutrient treatment of childhood psychosis.

Authors:  Megan Rodway; Annette Vance; Amany Watters; Helen Lee; Elske Bos; Bonnie J Kaplan
Journal:  BMJ Case Rep       Date:  2012-11-09

2.  Clinically Significant Symptom Reduction in Children with Attention-Deficit/Hyperactivity Disorder Treated with Micronutrients: An Open-Label Reversal Design Study.

Authors:  Heather A Gordon; Julia J Rucklidge; Neville M Blampied; Jeanette M Johnstone
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-12       Impact factor: 2.576

3.  Database analysis of children and adolescents with bipolar disorder consuming a micronutrient formula.

Authors:  Julia J Rucklidge; Dermot Gately; Bonnie J Kaplan
Journal:  BMC Psychiatry       Date:  2010-09-28       Impact factor: 3.630

Review 4.  Broad-spectrum micronutrient treatment for attention-deficit/hyperactivity disorder: rationale and evidence to date.

Authors:  Julia J Rucklidge; Bonnie J Kaplan
Journal:  CNS Drugs       Date:  2014-09       Impact factor: 5.749

5.  Nutritional and safety outcomes from an open-label micronutrient intervention for pediatric bipolar spectrum disorders.

Authors:  Elisabeth A Frazier; Barbara Gracious; L Eugene Arnold; Mark Failla; Chureeporn Chitchumroonchokchai; Diane Habash; Mary A Fristad
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-10       Impact factor: 2.576

6.  Systematic review of safety and tolerability of a complex micronutrient formula used in mental health.

Authors:  J Steven A Simpson; Susan G Crawford; Estelle T Goldstein; Catherine Field; Ellen Burgess; Bonnie J Kaplan
Journal:  BMC Psychiatry       Date:  2011-04-18       Impact factor: 3.630

7.  The mind-body-microbial continuum.

Authors:  Antonio Gonzalez; Jesse Stombaugh; Catherine Lozupone; Peter J Turnbaugh; Jeffrey I Gordon; Rob Knight
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

8.  Rationale and design of an international randomized placebo-controlled trial of a 36-ingredient micronutrient supplement for children with ADHD and irritable mood: The Micronutrients for ADHD in Youth (MADDY) study.

Authors:  Jeanette M Johnstone; Brenda Leung; Barbara Gracious; Leanna Perez; Gabriella Tost; Andrew Savoy; Irene Hatsu; Andrew Hughes; Alisha Bruton; L Eugene Arnold
Journal:  Contemp Clin Trials Commun       Date:  2019-10-26

Review 9.  Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain.

Authors:  Hao-Ming Xu; Hong-Li Huang; You-Lian Zhou; Hai-Lan Zhao; Jing Xu; Di-Wen Shou; Yan-Di Liu; Yong-Jian Zhou; Yu-Qiang Nie
Journal:  Gastroenterol Res Pract       Date:  2021-01-16       Impact factor: 2.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.